GEHC GE HealthCare Technologies ...

Nasdaq


$ 74.04 $ 2.44 (3.37 %)    

Thursday, 20-Nov-2025 16:42:46 EST
QQQ $ 584.62 $ -14.20 (-2.37 %)
DIA $ 458.30 $ -3.66 (-0.79 %)
SPY $ 652.19 $ -10.10 (-1.52 %)
TLT $ 89.30 $ 0.35 (0.39 %)
GLD $ 375.00 $ -0.11 (-0.03 %)
$ 74.75
$ 73.13
$ 74.74 x 100
$ 75.48 x 1
-- - --
$ 57.57 - $ 94.66
8,322,431
na
33.93B
$ 1.29
$ 15.30
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-29-2025 09-30-2025 10-Q
2 07-30-2025 06-30-2025 10-Q
3 04-30-2025 03-31-2025 10-Q
4 02-13-2025 12-31-2024 10-K
5 10-30-2024 09-30-2024 10-Q
6 07-31-2024 06-30-2024 10-Q
7 04-30-2024 03-31-2024 10-Q
8 02-06-2024 12-31-2023 10-K
9 10-31-2023 09-30-2023 10-Q
10 07-25-2023 06-30-2023 10-Q
11 04-25-2023 03-31-2023 10-Q
12 02-15-2023 12-31-2022 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 ge-healthcare-signs-agreement-to-acquire-intelerad-for-23b-in-cash

GE HealthCare (Nasdaq: GEHC) announced it has entered into an agreement to acquire Intelerad, a leading medical imaging softwar...

Core News & Articles

Today, GE HealthCare (Nasdaq: GEHC) and DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly owned s...

 morgan-stanley-maintains-equal-weight-on-ge-healthcare-techs-raises-price-target-to-80

Morgan Stanley analyst Patrick Wood maintains GE HealthCare Techs (NASDAQ:GEHC) with a Equal-Weight and raises the price tar...

 evercore-isi-group-maintains-outperform-on-ge-healthcare-techs-raises-price-target-to-92

Evercore ISI Group analyst Vijay Kumar maintains GE HealthCare Techs (NASDAQ:GEHC) with a Outperform and raises the price ta...

 wells-fargo-maintains-overweight-on-ge-healthcare-techs-lowers-price-target-to-87

Wells Fargo analyst Larry Biegelsen maintains GE HealthCare Techs (NASDAQ:GEHC) with a Overweight and lowers the price targe...

 tariffs-bite-into-ge-healthcare-q3-profit-margin

GE HealthCare Q3 earnings beat estimates as sales rise 6% and orders grow 6% organically, prompting a raised full-year profit o...

 ge-healthcare-techs-raises-fy2025-adj-eps-guidance-from-443-463-to-451-463-vs-453-est

GE HealthCare Techs (NASDAQ:GEHC) raises FY2025 Adj EPS guidance from $4.43-$4.63 to $4.51-$4.63 vs $4.53 analyst estimate..

 ge-healthcare-techs-q3-adj-eps-107-beats-105-estimate-sales-5143b-beat-5079b-estimate

GE HealthCare Techs (NASDAQ:GEHC) reported quarterly earnings of $1.07 per share which beat the analyst consensus estimate of $...

 ge-healthcare-receives-ce-mark-for-carevance-patient-monitor-expanding-access-to-advanced-monitoring-across-europe

Built on GE HealthCare's 50+ years of clinical excellence in patient monitoring, Carevance is an advanced, reliable monitor...

 ge-healthcare-partnering-with-the-queens-health-systems-duke-health-to-enhance-hospital-operations-patient-care-through-new-ai-driven-hospital-operations-platform

GE HealthCare (NASDAQ:GEHC) today announced collaborations with two leading U.S. health systems—The Queen's Health Systems ...

 btig-maintains-buy-on-ge-healthcare-techs-raises-price-target-to-89

BTIG analyst Ryan Zimmerman maintains GE HealthCare Techs (NASDAQ:GEHC) with a Buy and raises the price target from $87 to $89.

 barclays-initiates-coverage-on-ge-healthcare-techs-with-equal-weight-rating-announces-price-target-of-86

Barclays analyst Matt Miksic initiates coverage on GE HealthCare Techs (NASDAQ:GEHC) with a Equal-Weight rating and announce...

 citigroup-downgrades-ge-healthcare-techs-to-neutral-lowers-price-target-to-83

Citigroup analyst Joanne Wuensch downgrades GE HealthCare Techs (NASDAQ:GEHC) from Buy to Neutral and lowers the price targe...

 trump-administration-review-targets-medical-supply-chain-vulnerabilities

The U.S. Commerce Department, under the Trump administration, has launched a national security review of medical imports—includ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION